Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul 15;5(7):132-8.
doi: 10.4251/wjgo.v5.i7.132.

Risk factors and classifications of hilar cholangiocarcinoma

Affiliations

Risk factors and classifications of hilar cholangiocarcinoma

Miguel Angel Suarez-Munoz et al. World J Gastrointest Oncol. .

Abstract

Cholangiocarcinoma is the second most common primary malignant tumor of the liver. Perihilar cholangiocarcinoma or Klatskin tumor represents more than 50% of all biliary tract cholangiocarcinomas. A wide range of risk factors have been identified among patients with Perihilar cholangiocarcinoma including advanced age, male gender, primary sclerosing cholangitis, choledochal cysts, cholelithiasis, cholecystitis, parasitic infection (Opisthorchis viverrini and Clonorchis sinensis), inflammatory bowel disease, alcoholic cirrhosis, nonalcoholic cirrhosis, chronic pancreatitis and metabolic syndrome. Various classifications have been used to describe the pathologic and radiologic appearance of cholangiocarcinoma. The three systems most commonly used to evaluate Perihilar cholangiocarcinoma are the Bismuth-Corlette (BC) system, the Memorial Sloan-Kettering Cancer Center and the TNM classification. The BC classification provides preoperative assessment of local spread. The Memorial Sloan-Kettering cancer center proposes a staging system according to three factors related to local tumor extent: the location and extent of bile duct involvement, the presence or absence of portal venous invasion, and the presence or absence of hepatic lobar atrophy. The TNM classification, besides the usual descriptors, tumor, node and metastases, provides additional information concerning the possibility for the residual tumor (R) and the histological grade (G). Recently, in 2011, a new consensus classification for the Perihilar cholangiocarcinoma had been published. The consensus was organised by the European Hepato-Pancreato-Biliary Association which identified the need for a new staging system for this type of tumors. The classification includes information concerning biliary or vascular (portal or arterial) involvement, lymph node status or metastases, but also other essential aspects related to the surgical risk, such as remnant hepatic volume or the possibility of underlying disease.

Keywords: Bile duct cancer; Hilar cholangiocarcinoma; Klatskin tumor; Perihilar cholangiocarcinoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Morphologic classification of cholangiocarcinoma. A: Mass-forming; B: Periductal-infiltrating; C: Intraductal-growing.
Figure 2
Figure 2
Bismuth-Corlette classification of Perihilar (Klatskin) tumors. TypeI: Proximal bile duct tumor that do not extend to the bifurcation; TypeII: Tumor extend to the bifurcation without extension into the intrahepatic bile ducts; TypeIIIa: Tumoral occlusion of the common hepatic duct and the right hepatic duct; TypeIIIb: Tumoral occlusion of the common hepatic duct and the left hepatic duct; Type IV: Tumor involving the confluence and both the right and left hepatic ducts.
Figure 3
Figure 3
Consensus classification from the European Hepato-Pancreato-Biliary Association. Involvement of the portal vein or hepatic artery is considered when the tumor encompasses more than 180º of the circumference. A: Biliary involvement (B), based on the Bismuth-Corlette classification; B: Portal involvement; C: Arterial involvement. Adapted from Deoliveira et al [24].

References

    1. Jarnagin WR, Shoup M. Surgical management of cholangiocarcinoma. Semin Liver Dis. 2004;24:189–199. - PubMed
    1. Friman S. Cholangiocarcinoma--current treatment options. Scand J Surg. 2011;100:30–34. - PubMed
    1. Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, Fang Y, Wiangnon S, Sripa B, Hong ST. Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia. Asian Pac J Cancer Prev. 2010;11:1159–1166. - PubMed
    1. Khan SA, Emadossadaty S, Ladep NG, Thomas HC, Elliott P, Taylor-Robinson SD, Toledano MB. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol. 2012;56:848–854. - PubMed
    1. Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, McGlynn KA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol. 2007;5:1221–1228. - PMC - PubMed

LinkOut - more resources